Displaying 16 (all) recruiting clinical trials.
-
A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma Grade IIIb Follicular Lymphoma transformed lymphoma and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
The purpose of the study is to evaluate the study drug CC-486 (oral azacitidine) plus the standard drug therapy that fights cancer cells for patients ... -
A Phase 2/3 Randomized Open-Label Study of Maintenance GRT-C901/GRT-R902 A Neoantigen Vaccine in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer
The purpose of the study is to demonstrate clinical efficacy and characterize the clinical activity relating to the maintenance therapy with GRT-C901/GRT-R902 in combination ... -
NRG-GI008: COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE (CIRCULATE-US)
You can participate in this study if you are diagnosed with stage 2 or stage 3 colon cancer. The purpose of this study is to ...
-
Presence or Absence of blood in the GI lumen Correlating a HemoPill acute measurement with a subsequent endoscopic finding
The HemoPill acute is a swallowable capsule device that has the capability to detect blood in the upper digestive tract. Bleedings in the upper digestive ... -
Assessment of the Efficacy Safety and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease
The purpose of this study is to learn about the effects of a study medicine, Epetraborole, to assess the efficacy for treating refractory MAC, to ... -
A Phase 2/3 Randomized Double-Blinded Placebo-Controlled Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
The main goal of this study is to see if the investigational drug is safe and effective in treating people with bullous pemphigoid (BP). The ...